insights_auto
Why is INO down ३.१०%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
US$ १.४०
arrow_downward
-३.१०%(-०.०४५) 1D
नोभेम्बर ११, १५:११:२० GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
US$ १.३७
High
US$ १.४४
Low
US$ १.३०
Mkt. cap
२३.७३ करोड
Avg. vol.
१.८८ करोड
Volume
८६.३५ लाख
52-wk high
US$ २.७२
52-wk low
US$ ०.५७
EPS
-US$ १.१७
Beta
१.७१
Shares outstanding
१०.३४ करोड
No. of employees
११२
Open
US$ १.३७
High
US$ १.४४
Low
US$ १.३०
Mkt. cap
२३.७३ करोड
Avg. vol.
१.८८ करोड
Volume
८६.३५ लाख
52-wk high
US$ २.७२
52-wk low
US$ ०.५७
EPS
-US$ १.१७
Beta
१.७१
Shares outstanding
१०.३४ करोड
No. of employees
११२
News stories
From web sources and news partners
GuruFocus
·
४ घण्टा पहिले
INO Reiterated by Piper Sandler -- Price Target Lowered to $6.00
Yahoo Finance
·
७ घण्टा पहिले
INOVIO to Participate in Upcoming Investor Conferences
GuruFocus
·
१६ घण्टा पहिले
FMR LLC Adds Inovio Pharmaceuticals Inc (INO) Shares -- Stock Looks 625% Overvalued on GF Value
Yahoo Finance
·
१७ घण्टा पहिले
Inovio Pharmaceuticals Q3 Earnings Call Highlights
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc